简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2017-11-03 14:17 AltemiaTM Achieves Successful Clinical Results in Pediatric Patients with Sickle Cell Disease (SCD)
2017-11-03 09:48 Boehringer Ingelheim and Dicerna Announce Collaboration to Develop Novel Treatments for Chronic Liver Diseases including Nonalcoholic Steatohepatitis (NASH)
2017-11-03 09:46 Philip Morris International Outlines Its Scientific Assessment Program and Results for Its Electronically Heated Tobacco Product (IQOS) in Latest Scientific Update for Smoke-Free Products
2017-11-02 18:37 Takeda Reports First Half FY2017 Results
2017-11-02 13:55 PMC Group International Announces Acquisition of Pharma Company in India
2017-10-31 15:34 GRAMINEX L.L.C. expands its partnership with IDIPharma after clinical study publication.
2017-10-31 09:54 Boehringer Ingelheim expands collaboration with Sarah Cannon Research Institute to investigate novel immuno-oncology combination therapy
2017-10-30 10:51 Efficacy and Safety Results from Second Phase III Trial (RADIANCE™ Part B) of Oral Ozanimod Versus an Active Comparator in Relapsing Multiple Sclerosis Presented at MSParis2017 – 7th Joint ECTRIMS – ACTRIMS Meeting
2017-10-30 10:43 Efficacy and Safety Results from First Phase III Trial of Oral Ozanimod (SUNBEAM™) Versus an Active Comparator in Relapsing Multiple Sclerosis Presented at MSParis2017 – 7th Joint ECTRIMS – ACTRIMS Meeting
2017-10-26 09:44 Janssen’s New Darunavir-Based Single Tablet Regimen SYMTUZA® Shows Positive Outcome in Treatment of Antiretroviral-Naïve HIV Patients
2017-10-25 14:02 ABEC 4,000 Liter Single-Use Bioreactor to Expand Emergent BioSolutions Manufacturing Capability
2017-10-24 09:22 Hallstar’s New Photostabilizer, AvoBrite®, Solves Customers’ Regulatory Challenges While Delivering Outstanding Photoprotection
2017-10-20 09:34 Phase III Efficacy and Safety Data for Oral Ozanimod in Relapsing Multiple Sclerosis to Be Presented at MSParis2017 – 7th Joint ECTRIMS – ACTRIMS Meeting
2017-10-17 15:40 Takeda Presents Updated Results from Pivotal Phase 2 ALTA Trial of ALUNBRIGTM (brigatinib) in ALK-Positive Non-Small Cell Lung Cancer
2017-10-17 09:50 AstraZeneca and Chi-Med’s Savolitinib Shows Encouraging Clinical Activity in 2nd-Line EGFR Mutation-positive Lung Cancer with MET-amplification
2017-10-17 09:48 Results from Phase 2 Studies of Oral Ozanimod in Crohn’s Disease and Ulcerative Colitis to Be Presented at World Congress of Gastroenterology at ACG2017
2017-10-16 10:02 Herbalife Nutrition Survey Reveals APAC Consumers Concerned About Aging-Related Health Issues but Underestimate the Importance of Nutrition in Healthy Aging
2017-10-16 09:58 FASLODEX (FULVESTRANT) RECEIVES POSITIVE CHMP OPINION FOR THE TREATMENT OF HORMONE RECEPTOR-POSITIVE ADVANCED BREAST CANCER IN COMBINATION WITH PALBOCICLIB1
2017-10-13 10:14 VitalityLife Provides Innovative Health Services and More Accurate Underwriting with Munich Re’s ALLFINANZ Underwriting Software
2017-10-12 12:48 Harbour BioMed Announces Multi-Year Transgenic Platform Licensing Agreement with Innovent Biologics, Inc. for Fully Human Monoclonal Antibody Drug Discovery

Business Wire Weibo

Press Releases

Latest Releases